Gerdau (GGB) Earnings Analysis
Gerdau (GGB) next reports earnings on 2026-07-30, consensus EPS 0.15 USD. Last quarter (2026-04-27) it missed with EPS 0.1 USD vs 0.15 USD est (-33.3%). It has beaten estimates in 1/7 recent quarters (14%). Trailing P/E n/a.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does GGB next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 0.15 USD |
| Revenue estimate | 3.42B |
GGB earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-27 | 0.1 USD | 0.15 USD | -33.3% | Miss |
| 2026-02-23 | 0.07 USD | 0.11 USD | -36.4% | Miss |
| 2025-10-30 | 0.1 USD | 0.11 USD | -9.1% | Miss |
| 2025-07-31 | 0.08 USD | 0.09 USD | -11.1% | Miss |
| 2025-04-28 | 0.06 USD | 0.1 USD | -40% | Miss |
| 2025-02-19 | 0.06 USD | 0.12 USD | -50% | Miss |
| 2024-07-31 | 0.09 USD | 0.07 USD | +28.6% | Beat |
Beat rate: 1/7 (14%) over reported quarters with consensus data.
GGB valuation and analyst view
| Trailing P/E | n/a |
|---|---|
| Trailing EPS | n/a |
| Price / book | n/a |
| Dividend yield | n/a |
| Market cap | 9.40B |
| Analyst consensus | Buy (7 buy / 1 hold / 2 sell) |
| Avg price target | 5.25 USD |
Related research pages
Frequently asked questions
When is Gerdau (GGB)'s next earnings date?
Gerdau is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 0.15 USD and revenue estimate of 3.42B.
Did GGB beat earnings last quarter?
In its 2026-04-27 report, GGB posted EPS of 0.1 USD versus a 0.15 USD estimate — a miss of 33.3%.
What is GGB's earnings track record?
Over the last 7 reported quarters with consensus data, GGB beat estimates 1 times (14%).
What is GGB's current P/E ratio and EPS?
GGB trades at a trailing P/E of n/a on trailing EPS of n/a.
What do analysts rate GGB?
Analyst consensus is "Buy" across 10 ratings (0 strong buy, 7 buy, 1 hold, 2 sell, 0 strong sell). Average 12-month price target: 5.25 USD.